Anti-CD38 x Anti-CD59 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD38 and anti-CD59 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can recruit complement to tumor cells. It is designed for the research of Multiple myeloma (MM); Hematologic malignancies therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY